Haleon HLN
NYSE HLN
$9.87 -0.01 (-0.10%)
At close: Aug 20, 2026 · 4:00 PM EDT

Haleon (HLN) EBT Growth (3y) (2025)

Haleon (HLN) EBT Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 21.00%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn -0.23%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 1.19%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 3.60%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -29.91%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 10.08%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 39.40%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Alkermes 8.02 Bn 7.37 Bn 397.90 Mn -26.13%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.32%